AISAP Cardio vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
AISAP Cardio focuses on AI-powered interpretation of point-of-care ultrasound for rapid cardiac diagnostic assessments at the bedside. In contrast, IM007 provides an AI-powered platform for remote monitoring and management of data from cardiac implantable electronic devices. While both leverage AI in cardiology to improve patient outcomes, they address distinct clinical workflows and data sources.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
AISAP Cardio is an AI-powered point-of-care ultrasound (POCUS) software platform providing rapid, comprehensive cardiac diagnostic assessments and measurements at the bedside, focusing on early detection of structural heart disease and heart failure. IM007, conversely, is an AI-powered, cloud-based platform for remote cardiac monitoring that aggregates data from all cardiac implantable electronic devices (CIEDs) to streamline workflows and reduce false alerts.
AISAP Cardio aids in heart failure management by enabling early detection through rapid, comprehensive cardiac diagnostic assessments and measurements from POCUS, including LVEF. IM007 supports heart failure management with its FDA-cleared SignalHF feature, a predictive AI designed to assess heart failure hospitalization risk based on CIED data.
AISAP Cardio analyzes cardiac ultrasound images to provide AI-powered interpretations, measurements of ventricular dimensions, atrial areas, and assessment of valvular pathologies. IM007 aggregates and analyzes data specifically from various cardiac implantable electronic devices (CIEDs) from multiple manufacturers, such as Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort.
AISAP Cardio is described as a vendor-agnostic solution, suggesting compatibility with various ultrasound equipment. IM007 is vendor-agnostic in its ability to aggregate data from all major cardiac implantable electronic device (CIED) manufacturers.
AISAP Cardio is an FDA-cleared AI-powered POCUS software platform for cardiac diagnostic assessments. IM007 has overall FDA clearance for its AI-powered remote cardiac monitoring platform, including specific FDA clearances for its ILR ECG Analyzer and SignalHF predictive AI for heart failure hospitalization risk.
AISAP Cardio is designed for integration with existing clinical workflows, EHR/EMR, and PACS systems. IM007 offers EHR integration capabilities through a bidirectional API and integration framework, and also provides smart workflow automation for billing, reporting, and scheduling related to remote monitoring.